GAURI R VARADHACHARY to Cost-Benefit Analysis
This is a "connection" page, showing publications GAURI R VARADHACHARY has written about Cost-Benefit Analysis.
Connection Strength
0.207
-
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement. Ann Surg Oncol. 2012 Nov; 19(12):3659-67.
Score: 0.081
-
Gene expression profiling in cancers of unknown primary. J Clin Oncol. 2009 Sep 01; 27(25):e85-6; author reply e87-8.
Score: 0.065
-
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis. Ann Surg Oncol. 2013 Jul; 20(7):2197-203.
Score: 0.021
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
Score: 0.021
-
Cost-effectiveness of gene-expression profiling for tumor-site origin. Value Health. 2013 Jan-Feb; 16(1):46-56.
Score: 0.021